✦ LIBER ✦

Are RAS mutations predictive markers of resistance to standard chemotherapy?

✍ Scribed by Loriot, Yohann; Mordant, Pierre; Deutsch, Eric; Olaussen, Ken André; Soria, Jean-Charles

Book ID: 111975558
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 198 KB
Volume: 6
Category: Article
ISSN: 1759-4774
DOI: 10.1038/nrclinonc.2009.106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allelic Imbalance atp53and Microsatellit

Allelic Imbalance atp53and Microsatellite Instability Are Predictive Markers for Resistance to Chemotherapy in Gastric Carcinoma

✍ Masakazu Yashiro; Toru Inoue; Nobuaki Nishioka; Tasuku Matsuoka; C. Richard Bola 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 334 KB

P11 Which MR parameters are relevant as

P11 Which MR parameters are relevant as predictive markers of tumor response to radio and chemotherapy?

✍ B. Jordan; B. Gallez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPT

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer

✍ Jorma J. de Ronde, Esther H. Lips, Lennart Mulder, Andrew D. Vincent, Jelle Wess 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 614 KB

Sequential assessment of multidrug resis

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy

✍ Sylvie Chevillard; Pierre Pouillart; Chérif Beldjord; Bernard Asselain; Philippe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

The authors examined the relevance of S-phase fraction (SPF) and multidrug resistance (MDR) phenotype as predictive tests of breast cancer response in a series of patients treated by conventional doses of neoadjuvant chemotherapy with (FAC) or without (FTC) doxorubicin. ## METHODS. Fine needle sa

Reply to ‘Wilms' tumour 1 mutations are

Reply to ‘Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML’ by Summers et al.

✍ Nyvold, C G; Ommen, H B; Østergaard, M; Hokland, P 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

744 ABSENCE OF ACTIVATING MUTATIONS OF E

744 ABSENCE OF ACTIVATING MUTATIONS OF EGFRAND HER-2/NEU AS PREDICTIVE MARKERS FOR RESPONSE TO TYROSINE-KINASE INHIBITORS IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER

✍ C.H. Ohlmann; G. Braun; V. Jung; M. Stöckle; U. Engelmann; A. Heidenreich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB